162 related articles for article (PubMed ID: 22275998)
1. Distinct pattern of mutations of conserved regions of TP53 in colorectal cancer patients in the Kashmir population: an emerging high-risk area.
Rehman S; Sameer A; Zahoor L; Abdullah S; Shah Z; Afroze D; Hussain I; Shaffi S; Syeed N; Rizvi M; Siddiqi M
Ecancermedicalscience; 2009; 3():129. PubMed ID: 22275998
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
3. Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area.
Sameer AS; ul Rehman S; Pandith AA; Syeed N; Shah ZA; Chowdhri NA; Wani KA; Siddiqi MA
Saudi J Gastroenterol; 2009; 15(4):244-52. PubMed ID: 19794270
[TBL] [Abstract][Full Text] [Related]
4. Mutational spectrum of conserved regions of TP53 and PTEN genes in Kangri cancer (of the skin) in the Kashmiri population.
Hussain I; ul Rehman S; Afroze D; Zahoor L; Abdullah S; Hafiz A; Shah ZA; Iqbal S; Shaffi M; Das BC; Siddiqi MA
Mutat Res; 2009 May; 676(1-2):5-10. PubMed ID: 19486858
[TBL] [Abstract][Full Text] [Related]
5. TP53 - molecular soldier's mutations in bladder cancer in the Kashmiri population.
Nanda MS; Shah ZA; Sameer AS; Syeed N; Murtaza I; Siddiqi MA; Ali A
Asian Pac J Cancer Prev; 2011; 12(1):67-72. PubMed ID: 21517233
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area.
Mir MM; Dar NA; Gochhait S; Zargar SA; Ahangar AG; Bamezai RN
Int J Cancer; 2005 Aug; 116(1):62-8. PubMed ID: 15761872
[TBL] [Abstract][Full Text] [Related]
8. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
9. Different mutation profiles associated to P53 accumulation in colorectal cancer.
López I; P Oliveira L; Tucci P; Alvarez-Valín F; A Coudry R; Marín M
Gene; 2012 May; 499(1):81-7. PubMed ID: 22373952
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors.
Pütz A; Hartmann AA; Fontes PR; Alexandre CO; Silveira DA; Klug SJ; Rabes HM
Int J Cancer; 2002 Mar; 98(1):99-105. PubMed ID: 11857392
[TBL] [Abstract][Full Text] [Related]
11. Correlation of TP53 mutations and p53 expression in ovarian tumors.
DiCioccio RA; Werness BA; Peng R; Allen HJ; Piver MS
Cancer Genet Cytogenet; 1998 Sep; 105(2):93-102. PubMed ID: 9723023
[TBL] [Abstract][Full Text] [Related]
12. DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications.
Klumb CE; Furtado DR; de Resende LM; Carriço MK; Coelho AM; de Meis E; Maia RC; Rumjanek FD
Eur J Haematol; 2003 Aug; 71(2):81-90. PubMed ID: 12890146
[TBL] [Abstract][Full Text] [Related]
13. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
Berns EM; van Staveren IL; Look MP; Smid M; Klijn JG; Foekens JA
Br J Cancer; 1998 Apr; 77(7):1130-6. PubMed ID: 9569050
[TBL] [Abstract][Full Text] [Related]
14. Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
Manoharan V; Karunanayake EH; Tennekoon KH; De Silva S; Imthikab AIA; De Silva K; Angunawela P; Vishwakula S; Lunec J
BMC Cancer; 2020 Jan; 20(1):72. PubMed ID: 32000721
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations in Romanian patients with colorectal cancer.
Manirakiza F; Yamada H; Iwashita Y; Ishino K; Ishikawa R; Kovacs Z; Osvath E; Nzitakera A; Gurzu S; Sugimura H
Genes Environ; 2023 Jul; 45(1):20. PubMed ID: 37391803
[TBL] [Abstract][Full Text] [Related]
16. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
17. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley.
Murtaza I; Mushtaq D; Margoob MA; Dutt A; Wani NA; Ahmad I; Bhat ML
World J Gastroenterol; 2006 Jul; 12(25):4033-7. PubMed ID: 16810754
[TBL] [Abstract][Full Text] [Related]
18. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of codon 213Arg-->Stop mutations of the TP53 gene in human ovarian cancer in the southwestern part of The Netherlands.
Schuyer M; Henzen-Logmans SC; van der Burg ME; Fieret EJ; Klijn JG; Foekens JA; Berns EM
Int J Cancer; 1998 May; 76(3):299-303. PubMed ID: 9579562
[TBL] [Abstract][Full Text] [Related]
20. Analysis of K-ras codon 12 and TP53 mutations in patients with advanced colorectal carcinoma.
Parker MI; Zhunussova G; Djansugurova L; Khussainova E; Zhunusbekova B; Afonin G; Khaidarova D; Matejcic M
S Afr Med J; 2015 Sep; 105(8):670-4. PubMed ID: 26449693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
